Keyphrases
Alphavirus
75%
Ruxolitinib
65%
COVID-19
62%
Primary Antibody Deficiency
50%
Cytomegalovirus Infection
50%
Thrombosis
50%
Cytomegalovirus
50%
Alphavirus Infection
50%
STAT1 Gain-of-function mutation
48%
Janus Kinase Inhibitors
48%
STAT1 Gain of Function
46%
Replacement Product
40%
Immunoglobulin Replacement
40%
ISTAT
39%
Antibody Deficiency
35%
Emergency Department
35%
Neutralizing Activity
35%
Receptor-binding Domain
35%
Interferon-α (IFN-α)
32%
Autoimmunity
32%
Israel
29%
Omicron Variant
29%
Influenza-like Illness
29%
Antibody Response
28%
Vertebrates
25%
IgG1
25%
Class-specific
25%
Memory B-cell Response
25%
Binding Mode
25%
Opinion Survey
25%
STAT3 mutation
25%
STAT1 Pathway
25%
Heteroresistance
25%
African Immigrants
25%
Fungal Diseases
25%
Booster Vaccination
25%
Chronic Schistosomiasis
25%
Specific Binding
25%
Crowdsourced Data
25%
Bovinae
25%
MXRA8
25%
Patient Outcomes
25%
Analgesia
25%
Serum Levels
25%
Transcriptional Signature
25%
MRNA Vaccine
25%
Non-endemic
25%
Dephosphorylation
25%
Outcome Prediction
25%
Clinical Strains
25%
Immunology and Microbiology
STAT1
100%
Severe Acute Respiratory Syndrome Coronavirus 2
75%
Alphavirus
75%
Humoral Immune Deficiency
50%
Intravenous Immunoglobulin
41%
Gain of Function Mutation
37%
Receptor Binding
37%
Omicron Coronavirus Variant
31%
Primary Immunodeficiency
30%
Antibody Response
28%
Viral Disease
27%
Influenza A Virus (H1N1)
25%
Autoimmune Regulator
25%
Memory B Cell
25%
Cytomegalovirus
25%
Blood Level
25%
Binding Site
25%
C-Reactive Protein
25%
Immunoglobulin G1
25%
Immunomodulation
25%
Hematopoietic Cell
25%
Natural Killer Cell
25%
Cytomegalovirus Infection
25%
STAT3
25%
Upregulation
25%
Candida Glabrata
25%
Evolution
25%
Aves
20%
Immunoglobulin M
18%
interferon
16%
Cell Transplantation
15%
Spike
15%
COVID-19
14%
Bovine
12%
Drug Response
12%
Severe Combined Immunodeficiency
12%
Phylogeny
12%
Drug Megadose
12%
Cladistics
12%
Chronic Mucocutaneous Candidiasis
11%
B Cell
10%
Autoimmune Polyendocrine Syndrome Type 1
10%
Immune Response
10%
Influenza
10%
Encephalitis
9%
Titer
8%
T Cell
7%
Clustered Regularly Interspaced Short Palindromic Repeat
7%
Antibody Titer
6%
Head
6%
Medicine and Dentistry
Ruxolitinib
43%
Emergency Department
37%
Influenza A (H1N1)
32%
Virus Infection
27%
Analgesia
25%
STAT1 Protein
25%
Cytomegalovirus Infection
25%
Factor A
25%
Humoral Immune Deficiency
25%
Adverse Outcome
25%
Gain of Function Mutation
25%
Abdominal Pain
25%
Natural Killer Cell
25%
Thrombosis
25%
Cytomegalovirus
25%
Schistosomiasis
25%
Janus Kinase
25%
Immigrant
25%
Immunoglobulin G1
25%
Hyperactivation
25%
Severe Acute Respiratory Syndrome Coronavirus 2
25%
Memory B Cell
25%
Ex Vivo
25%
C Reactive Protein
25%
Influenza A Virus (H1N1)
25%
Case-Control Study
25%
Thorax Radiography
20%
Artificial Respiration
20%
Interferon
18%
Surgeon
18%
Intensive Care Unit
15%
Infection
14%
Targeted Therapy
12%
Janus Kinase Inhibitor
12%
Cytokine
12%
Lung
12%
B Cell
10%
T-Cell Response
10%
Diagnosis
10%
Prognostic Factor
7%
COVID-19 Vaccine
7%
Immune Response
7%
Messenger RNA
7%
Acute Abdomen
6%
C-X-C Motif Chemokine 10
6%
Enzyme Linked Immunosorbent Assay
6%
Gene Expression
6%
Real-Time Polymerase Chain Reaction
6%
Interleukin 6
6%
Immunoblotting
6%
